{"title":"董事会对Covid-19疫苗项目的考虑","authors":"Erica L. Opitz, Diana Pérez Gomez","doi":"10.1002/bl.30189","DOIUrl":null,"url":null,"abstract":"<div>\n <p><i>Erica L. Opitz and Diana Perez Gomez are attorneys with Chamberlain Hrdlicka, a law firm headquartered in Houston, providing expertise on a variety of matters relating to corporate governance; commercial contract, mergers and acquisitions: and privately held securities, among others. In this article, they discuss the key factors that the board should weigh when deciding whether to require their employees to receive the COVID-19 vaccine</i>.</p>\n </div>","PeriodicalId":100193,"journal":{"name":"Board Leadership","volume":"2021 175","pages":"6-7"},"PeriodicalIF":0.0000,"publicationDate":"2021-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/bl.30189","citationCount":"1","resultStr":"{\"title\":\"Board Considerations for Covid-19 Vaccine Programs\",\"authors\":\"Erica L. Opitz, Diana Pérez Gomez\",\"doi\":\"10.1002/bl.30189\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n <p><i>Erica L. Opitz and Diana Perez Gomez are attorneys with Chamberlain Hrdlicka, a law firm headquartered in Houston, providing expertise on a variety of matters relating to corporate governance; commercial contract, mergers and acquisitions: and privately held securities, among others. In this article, they discuss the key factors that the board should weigh when deciding whether to require their employees to receive the COVID-19 vaccine</i>.</p>\\n </div>\",\"PeriodicalId\":100193,\"journal\":{\"name\":\"Board Leadership\",\"volume\":\"2021 175\",\"pages\":\"6-7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-05-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1002/bl.30189\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Board Leadership\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/bl.30189\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Board Leadership","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/bl.30189","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
Erica L. Opitz和Diana Perez Gomez是总部位于休斯顿的Chamberlain Hrdlicka律师事务所的律师，就与公司治理有关的各种事项提供专业知识;商业合同、兼并和收购以及私人持有的证券等。在本文中，他们讨论了董事会在决定是否要求员工接种COVID-19疫苗时应权衡的关键因素。
Board Considerations for Covid-19 Vaccine Programs
Erica L. Opitz and Diana Perez Gomez are attorneys with Chamberlain Hrdlicka, a law firm headquartered in Houston, providing expertise on a variety of matters relating to corporate governance; commercial contract, mergers and acquisitions: and privately held securities, among others. In this article, they discuss the key factors that the board should weigh when deciding whether to require their employees to receive the COVID-19 vaccine.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
